Carcinogenic DNA viruses such as high-risk human papillomaviruses (HPV) and Epstein-Barr-Virus (EBV) replicate during persistent infections as low-copy-number plasmids. EBV DNA replication is restricted by host cell replication licensing mechanisms. In contrast, copy number control of HPV genomes is not under cellular control but involves the viral sequence-specific DNA-binding E2 activator and E8 ∧ E2C repressor proteins. Analysis of HPV31 mutant genomes revealed that residues outside of the DNA-binding/dimerization domain of E8 ∧ E2C limit viral DNA replication, indicating that binding site competition or heterodimerization among E2 and E8∧ E2C proteins does not contribute to copy number control. Domain swap experiments demonstrated that the amino-terminal 21 amino acids of E8 ∧ E2C represent a novel, transferable DNA replication repressor domain, whose activity requires conserved lysine and tryptophan residues. Furthermore, E8∧ E2C(1-21)-GAL4 fusion proteins inhibited the replication of the plasmid origin of replication of EBV, suggesting that E8 ∧ E2C functions as a general replication repressor of extrachromosomal origins. This finding could be important for the development of novel therapies against persistent DNA tumor virus infections.DNA viruses such as certain types of human papillomaviruses (HPV) and Epstein-Barr-virus (EBV), a member of the human herpesvirus family, are of major clinical interest because infections with these viruses have been linked to the development of human malignancies. HPV types 16, 18, 31, and 45 represent the predominant etiological agents of cervical cancer, and EBV infection has been suggested to contribute to the development of a number of lymphomas and nasopharyngeal carcinoma (28,42,43). Both HPV and EBV replicate as extrachromosomal elements in the nucleus of human cells. Interestingly, papillomaviruses and EBV maintain their genomes at defined copy numbers (10 to 50 virus copies per EBV-infected cell and 100 virus copies per papillomavirusinfected cell) in cultured cells over long periods of time (1,3,10,16,39,40). This behavior in tissue culture is thought to reflect viral DNA replication during persistent infections in vivo.In the latent phase, EBV DNA replication initiates at oriP, whereas in the lytic (productive) phase, oriLyt is responsible for the replication of EBV DNA (12,40). In contrast to oriLyt, the activity of oriP requires the viral EBNA1 protein, and viral copy number is kept constant by host cell replication licensing mechanisms, which ensure that eukaryotic genomes are copied exactly once before cell division (1, 40, 41). Most likely, this is achieved by recruiting the human origin recognition complex to oriP (5,8,31).Papillomaviruses use a different strategy to successfully maintain their DNA at defined copy numbers. In contrast to oriP, papillomavirus origins are not subject to replication licensing, but appear to use copy number control mechanisms, which are not fully understood (10). Two viral proteins are essential for the activation of papilloma...